3 hours ago
1
JLGutierrez
Arrowhead Pharmaceuticals (NASDAQ:ARWR) sued Ionis Pharmaceuticals (NASDAQ:IONS) in a Delaware District Court on Wednesday as part of a patent dispute related to its lead candidate, plozasiran.
The lawsuit doesn’t seek monetary compensation but rather a declaratory judgment determining that Ionis’ (IJONS) U.S. Patent
English (US) ·